0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracorporeal Membrane Oxygenators (ECMO) Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-16X3720
Home | Market Reports | Health| Medical Devices & Equipment
Global Extracorporeal Membrane Oxygenators ECMO Market Insights Forecast to 2028
BUY CHAPTERS

Global Extracorporeal Membrane Oxygenators (ECMO) Market Research Report 2025

Code: QYRE-Auto-16X3720
Report
August 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Extracorporeal Membrane Oxygenators (ECMO) Market Size

The global market for Extracorporeal Membrane Oxygenators (ECMO) was valued at US$ 306 million in the year 2024 and is projected to reach a revised size of US$ 381 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Extracorporeal Membrane Oxygenators (ECMO) Market

Extracorporeal Membrane Oxygenators (ECMO) Market

Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life.
North American market for Extracorporeal Membrane Oxygenators (ECMO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Extracorporeal Membrane Oxygenators (ECMO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Extracorporeal Membrane Oxygenators (ECMO) include Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile Biomédica, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenators (ECMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenators (ECMO).
The Extracorporeal Membrane Oxygenators (ECMO) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Extracorporeal Membrane Oxygenators (ECMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenators (ECMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Extracorporeal Membrane Oxygenators (ECMO) Market Report

Report Metric Details
Report Name Extracorporeal Membrane Oxygenators (ECMO) Market
Accounted market size in year US$ 306 million
Forecasted market size in 2031 US$ 381 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Respiratory
  • Cardiac
  • Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile Biomédica, WEGO, Xijian Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Extracorporeal Membrane Oxygenators (ECMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Extracorporeal Membrane Oxygenators (ECMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Extracorporeal Membrane Oxygenators (ECMO) Market growing?

Ans: The Extracorporeal Membrane Oxygenators (ECMO) Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Extracorporeal Membrane Oxygenators (ECMO) Market size in 2031?

Ans: The Extracorporeal Membrane Oxygenators (ECMO) Market size in 2031 will be US$ 381 million.

Who are the main players in the Extracorporeal Membrane Oxygenators (ECMO) Market report?

Ans: The main players in the Extracorporeal Membrane Oxygenators (ECMO) Market are Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile Biomédica, WEGO, Xijian Medical

What are the Application segmentation covered in the Extracorporeal Membrane Oxygenators (ECMO) Market report?

Ans: The Applications covered in the Extracorporeal Membrane Oxygenators (ECMO) Market report are Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others

What are the Type segmentation covered in the Extracorporeal Membrane Oxygenators (ECMO) Market report?

Ans: The Types covered in the Extracorporeal Membrane Oxygenators (ECMO) Market report are Infant Paediatric Oxygenators, Adult Oxygenators

Recommended Reports

ECMO & Oxygenators

Extracorporeal Blood Systems

Oxygen Supply Devices

1 Extracorporeal Membrane Oxygenators (ECMO) Market Overview
1.1 Product Definition
1.2 Extracorporeal Membrane Oxygenators (ECMO) by Type
1.2.1 Global Extracorporeal Membrane Oxygenators (ECMO) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Infant Paediatric Oxygenators
1.2.3 Adult Oxygenators
1.3 Extracorporeal Membrane Oxygenators (ECMO) by Application
1.3.1 Global Extracorporeal Membrane Oxygenators (ECMO) Market Value by Application (2024 VS 2031)
1.3.2 Respiratory
1.3.3 Cardiac
1.3.4 Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
1.3.5 Others
1.4 Global Extracorporeal Membrane Oxygenators (ECMO) Market Size Estimates and Forecasts
1.4.1 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue 2020-2031
1.4.2 Global Extracorporeal Membrane Oxygenators (ECMO) Sales 2020-2031
1.4.3 Global Extracorporeal Membrane Oxygenators (ECMO) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Extracorporeal Membrane Oxygenators (ECMO) Market Competition by Manufacturers
2.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Extracorporeal Membrane Oxygenators (ECMO) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Extracorporeal Membrane Oxygenators (ECMO), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Product Type & Application
2.7 Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Date of Enter into This Industry
2.8 Global Extracorporeal Membrane Oxygenators (ECMO) Market Competitive Situation and Trends
2.8.1 Global Extracorporeal Membrane Oxygenators (ECMO) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Extracorporeal Membrane Oxygenators (ECMO) Players Market Share by Revenue
2.8.3 Global Extracorporeal Membrane Oxygenators (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Extracorporeal Membrane Oxygenators (ECMO) Market Scenario by Region
3.1 Global Extracorporeal Membrane Oxygenators (ECMO) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Region: 2020-2031
3.2.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Region: 2020-2025
3.2.2 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Region: 2026-2031
3.3 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region: 2020-2031
3.3.1 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region: 2020-2025
3.3.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region: 2026-2031
3.4 North America Extracorporeal Membrane Oxygenators (ECMO) Market Facts & Figures by Country
3.4.1 North America Extracorporeal Membrane Oxygenators (ECMO) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2031)
3.4.3 North America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Extracorporeal Membrane Oxygenators (ECMO) Market Facts & Figures by Country
3.5.1 Europe Extracorporeal Membrane Oxygenators (ECMO) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2031)
3.5.3 Europe Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Facts & Figures by Region
3.6.1 Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Sales by Region (2020-2031)
3.6.3 Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Facts & Figures by Country
3.7.1 Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2031)
3.7.3 Latin America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Type (2020-2031)
4.1.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Type (2020-2025)
4.1.2 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Type (2026-2031)
4.1.3 Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Type (2020-2031)
4.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Type (2020-2031)
4.2.1 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Type (2020-2025)
4.2.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Type (2026-2031)
4.2.3 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Type (2020-2031)
4.3 Global Extracorporeal Membrane Oxygenators (ECMO) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Application (2020-2031)
5.1.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Application (2020-2025)
5.1.2 Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Application (2026-2031)
5.1.3 Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Application (2020-2031)
5.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Application (2020-2031)
5.2.1 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Application (2020-2025)
5.2.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Application (2026-2031)
5.2.3 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Application (2020-2031)
5.3 Global Extracorporeal Membrane Oxygenators (ECMO) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Getinge
6.1.1 Getinge Company Information
6.1.2 Getinge Description and Business Overview
6.1.3 Getinge Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Getinge Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.1.5 Getinge Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Company Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LivaNova Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 Chalice Medical
6.4.1 Chalice Medical Company Information
6.4.2 Chalice Medical Description and Business Overview
6.4.3 Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.4.5 Chalice Medical Recent Developments/Updates
6.5 MicroPort
6.5.1 MicroPort Company Information
6.5.2 MicroPort Description and Business Overview
6.5.3 MicroPort Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MicroPort Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.5.5 MicroPort Recent Developments/Updates
6.6 NIPRO
6.6.1 NIPRO Company Information
6.6.2 NIPRO Description and Business Overview
6.6.3 NIPRO Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NIPRO Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.6.5 NIPRO Recent Developments/Updates
6.7 XENIOS
6.7.1 XENIOS Company Information
6.7.2 XENIOS Description and Business Overview
6.7.3 XENIOS Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 XENIOS Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.7.5 XENIOS Recent Developments/Updates
6.8 OriGen Biomedical
6.8.1 OriGen Biomedical Company Information
6.8.2 OriGen Biomedical Description and Business Overview
6.8.3 OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.8.5 OriGen Biomedical Recent Developments/Updates
6.9 EUROSETS S.r.l.
6.9.1 EUROSETS S.r.l. Company Information
6.9.2 EUROSETS S.r.l. Description and Business Overview
6.9.3 EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.9.5 EUROSETS S.r.l. Recent Developments/Updates
6.10 Braile Biomédica
6.10.1 Braile Biomédica Company Information
6.10.2 Braile Biomédica Description and Business Overview
6.10.3 Braile Biomédica Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Braile Biomédica Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.10.5 Braile Biomédica Recent Developments/Updates
6.11 WEGO
6.11.1 WEGO Company Information
6.11.2 WEGO Description and Business Overview
6.11.3 WEGO Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 WEGO Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.11.5 WEGO Recent Developments/Updates
6.12 Xijian Medical
6.12.1 Xijian Medical Company Information
6.12.2 Xijian Medical Description and Business Overview
6.12.3 Xijian Medical Extracorporeal Membrane Oxygenators (ECMO) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xijian Medical Extracorporeal Membrane Oxygenators (ECMO) Product Portfolio
6.12.5 Xijian Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Membrane Oxygenators (ECMO) Industry Chain Analysis
7.2 Extracorporeal Membrane Oxygenators (ECMO) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Membrane Oxygenators (ECMO) Production Mode & Process Analysis
7.4 Extracorporeal Membrane Oxygenators (ECMO) Sales and Marketing
7.4.1 Extracorporeal Membrane Oxygenators (ECMO) Sales Channels
7.4.2 Extracorporeal Membrane Oxygenators (ECMO) Distributors
7.5 Extracorporeal Membrane Oxygenators (ECMO) Customer Analysis
8 Extracorporeal Membrane Oxygenators (ECMO) Market Dynamics
8.1 Extracorporeal Membrane Oxygenators (ECMO) Industry Trends
8.2 Extracorporeal Membrane Oxygenators (ECMO) Market Drivers
8.3 Extracorporeal Membrane Oxygenators (ECMO) Market Challenges
8.4 Extracorporeal Membrane Oxygenators (ECMO) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Extracorporeal Membrane Oxygenators (ECMO) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Extracorporeal Membrane Oxygenators (ECMO) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Extracorporeal Membrane Oxygenators (ECMO) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Extracorporeal Membrane Oxygenators (ECMO) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Extracorporeal Membrane Oxygenators (ECMO), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Product Type & Application
 Table 12. Global Key Manufacturers of Extracorporeal Membrane Oxygenators (ECMO), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Extracorporeal Membrane Oxygenators (ECMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Membrane Oxygenators (ECMO) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Extracorporeal Membrane Oxygenators (ECMO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Region (2020-2025)
 Table 19. Global Extracorporeal Membrane Oxygenators (ECMO) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Region (2026-2031)
 Table 21. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Region (2020-2025)
 Table 23. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Region (2026-2031)
 Table 25. North America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units) by Type (2020-2025)
 Table 51. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units) by Type (2026-2031)
 Table 52. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Type (2020-2025)
 Table 53. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Type (2026-2031)
 Table 54. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Type (2020-2025)
 Table 57. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Type (2026-2031)
 Table 58. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units) by Application (2020-2025)
 Table 61. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units) by Application (2026-2031)
 Table 62. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Application (2020-2025)
 Table 63. Global Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Application (2026-2031)
 Table 64. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Application (2020-2025)
 Table 67. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Application (2026-2031)
 Table 68. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Application (2026-2031)
 Table 70. Getinge Company Information
 Table 71. Getinge Description and Business Overview
 Table 72. Getinge Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Getinge Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 74. Getinge Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. LivaNova Company Information
 Table 81. LivaNova Description and Business Overview
 Table 82. LivaNova Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. LivaNova Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 84. LivaNova Recent Developments/Updates
 Table 85. Chalice Medical Company Information
 Table 86. Chalice Medical Description and Business Overview
 Table 87. Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 89. Chalice Medical Recent Developments/Updates
 Table 90. MicroPort Company Information
 Table 91. MicroPort Description and Business Overview
 Table 92. MicroPort Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. MicroPort Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 94. MicroPort Recent Developments/Updates
 Table 95. NIPRO Company Information
 Table 96. NIPRO Description and Business Overview
 Table 97. NIPRO Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. NIPRO Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 99. NIPRO Recent Developments/Updates
 Table 100. XENIOS Company Information
 Table 101. XENIOS Description and Business Overview
 Table 102. XENIOS Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. XENIOS Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 104. XENIOS Recent Developments/Updates
 Table 105. OriGen Biomedical Company Information
 Table 106. OriGen Biomedical Description and Business Overview
 Table 107. OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 109. OriGen Biomedical Recent Developments/Updates
 Table 110. EUROSETS S.r.l. Company Information
 Table 111. EUROSETS S.r.l. Description and Business Overview
 Table 112. EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 114. EUROSETS S.r.l. Recent Developments/Updates
 Table 115. Braile Biomédica Company Information
 Table 116. Braile Biomédica Description and Business Overview
 Table 117. Braile Biomédica Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Braile Biomédica Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 119. Braile Biomédica Recent Developments/Updates
 Table 120. WEGO Company Information
 Table 121. WEGO Description and Business Overview
 Table 122. WEGO Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. WEGO Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 124. WEGO Recent Developments/Updates
 Table 125. Xijian Medical Company Information
 Table 126. Xijian Medical Description and Business Overview
 Table 127. Xijian Medical Extracorporeal Membrane Oxygenators (ECMO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xijian Medical Extracorporeal Membrane Oxygenators (ECMO) Product
 Table 129. Xijian Medical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Extracorporeal Membrane Oxygenators (ECMO) Distributors List
 Table 133. Extracorporeal Membrane Oxygenators (ECMO) Customers List
 Table 134. Extracorporeal Membrane Oxygenators (ECMO) Market Trends
 Table 135. Extracorporeal Membrane Oxygenators (ECMO) Market Drivers
 Table 136. Extracorporeal Membrane Oxygenators (ECMO) Market Challenges
 Table 137. Extracorporeal Membrane Oxygenators (ECMO) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Extracorporeal Membrane Oxygenators (ECMO)
 Figure 2. Global Extracorporeal Membrane Oxygenators (ECMO) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Extracorporeal Membrane Oxygenators (ECMO) Market Share by Type: 2024 & 2031
 Figure 4. Infant Paediatric Oxygenators Product Picture
 Figure 5. Adult Oxygenators Product Picture
 Figure 6. Global Extracorporeal Membrane Oxygenators (ECMO) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Extracorporeal Membrane Oxygenators (ECMO) Market Share by Application: 2024 & 2031
 Figure 8. Respiratory
 Figure 9. Cardiac
 Figure 10. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
 Figure 11. Others
 Figure 12. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Extracorporeal Membrane Oxygenators (ECMO) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Extracorporeal Membrane Oxygenators (ECMO) Sales (2020-2031) & (K Units)
 Figure 15. Global Extracorporeal Membrane Oxygenators (ECMO) Average Price (US$/Unit) & (2020-2031)
 Figure 16. Extracorporeal Membrane Oxygenators (ECMO) Report Years Considered
 Figure 17. Extracorporeal Membrane Oxygenators (ECMO) Sales Share by Manufacturers in 2024
 Figure 18. Global Extracorporeal Membrane Oxygenators (ECMO) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Extracorporeal Membrane Oxygenators (ECMO) Players: Market Share by Revenue in Extracorporeal Membrane Oxygenators (ECMO) in 2024
 Figure 20. Extracorporeal Membrane Oxygenators (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Extracorporeal Membrane Oxygenators (ECMO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Country (2020-2031)
 Figure 23. North America Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Region (2020-2031)
 Figure 35. China Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Extracorporeal Membrane Oxygenators (ECMO) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Extracorporeal Membrane Oxygenators (ECMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Extracorporeal Membrane Oxygenators (ECMO) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Extracorporeal Membrane Oxygenators (ECMO) by Type (2020-2031)
 Figure 57. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Extracorporeal Membrane Oxygenators (ECMO) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Extracorporeal Membrane Oxygenators (ECMO) by Application (2020-2031)
 Figure 60. Global Extracorporeal Membrane Oxygenators (ECMO) Price (US$/Unit) by Application (2020-2031)
 Figure 61. Extracorporeal Membrane Oxygenators (ECMO) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS